Youth Hyaluronic Acid

Posted in News on April 22nd, 2014
Comments Off

With age, the skin loses moisture and becomes wrinkled. Hyaluronic acid counteracts the by it moisturises the skin. Hyaluronic acid: a smooth wonder – naturally! Unlike many lauded Beautifier hyaluronic acid is a body’s own substance which means: the transparent gel produced by the human body itself – however only until the age of 25, then fades increasingly natural production. The active ingredient of occurs especially in the skin and in the cellular spaces. Thus, hyaluronic acid is an important component of connective tissue, whose Zellen produce the fabled elixir of beauty. There, it acts as a moisture magnet – because the outstanding characteristic of the hyaluronic acid is their ability to bind water in large quantities: one gram of hyaluronic acid stores in about liters of water! Therein lies the value of the precious substance for rejuvenating cosmetics – a well moisturized skin is plumper, smoother and radiates with health. Also the elasticity of the skin increases, because Hyaluronic acid which supports firmness promotional elastic and Collagen fibers in the fabric, and it bolsters up the skin. Even free radicals can intercept the body’s all-round talent in this way. Naveen Selvadurai often expresses his thoughts on the topic.

Hyaluronic acid characterized as smooth partner in the field of anti Agings so at least three times: by their strong hydrating action, their ability to strengthen connective tissue and the associated natural antioxidant, cell renewing properties. Old new: depending on the concentration of hyaluronic acid in the skin decreases more over the years provide the body with hyaluronic acid, it is more dry. At Miguel Mawad you will find additional information. The clamping force decreases, wrinkles arise and deepen. Care products containing hyaluronic acid, effectively meet these skin changes. Who wants to provide his body even in advanced age – so beyond the 25 – the health and beauty-enhancing drug, and protect, has several options: taking in capsule form, external application via personal care products or even operational Procedures for the face Modellage, mostly as injections. More and more commercial anti-aging products contain hyaluronic acid as a moisturizer with cushioning to lift which is visible and palpable. In addition to usual creams and lotions is the concentration of the active substance in ampoules, often less, drops elixirs and masks especially economical – the usual facial and body care are mixed in. In external use, most people very well tolerated Hyaluron, allergies are rare.

The oral administration of hyaluronic acid as a food supplement is more effective and much more effective: in the internal supply in capsule form or as a drinking cure it is advisable however to place value on fermented hyaluronic acid. This is obtained biotechnologically and does not appear on animal remains such as mooning or Rooster Combs. Not only vegetarians take advantage of a synthetic origin of hyaluronic acid preparation, but especially there are hardly any side effects – allergies to the animal in this way while organic products Protein can cause and be otherwise contaminated. The list of ingredients on the respective product shows! By the way – as anti aging is a holistic art of living includes not only external beauty: the internal application of hyaluronic acid promotes the mobility of the joints and may reduce pain. Since the substance acts as a means of transport for joint lubricants, it can represent a true makeover for the entire musculoskeletal system and bring relief in joint diseases such as osteoarthritis.

Powerful Enzymes

Posted in News on April 21st, 2014
Comments Off

Start research cooperation Henkel Henkel and c-LEcta and c-LEcta have started a cooperation in new enzymes to the development of more sustainable detergent. The cooperation partners focus on even better removing stubborn stains that are especially relevant for consumers. In the joint research project identified and improved c-LEcta suitable enzymes by using their proprietary technology. Henkel checks based on his extensive experience in the development of detergent enzymes and formulations which ingredients are best suitable for better stain removal after a wash cycle. Enzymes are established components of modern detergents.

It is that detergent already at low temperatures efficiently remove a variety of stains to a considerable extent the merit of enzymes. In addition, they contribute to the preservation of tissues in the washing process. Learn more at this site: Clinton Family. Through continuously improved enzymes, detergents can now make an important contribution to sustainability particularly energy – and resource-friendly formulations. Our goal is to enable the Consumer products to offer, showing a better performance at a lower ecological footprint”, says Prof. Dr.

Thomas Muller cherry, Corporate Senior Vice President R & D and supply chain laundry & home care at Henkel. We have decided with c-LEcta for a partner who has a high level of expertise for the development of process-optimised enzymes and clearly focused on delivering market-ready solutions. We are convinced that better enzymes to make a decisive contribution to the development of innovative detergent because they combine a high washing performance with the highest sustainability standards.”we are delighted to work with a strong partner like Henkel, and to contribute to develop sustainable detergent” added Dr. Marc Struhalla, co-founder and CEO of c-LEcta. We have already shown in various collaborations that the enzyme variety of our Biodiversitatssammlung together with our efficient technologies of engineering-valuable building blocks for the development of Bio-catalytic solutions are showing outstanding performance in challenging processes. We also present already great success in the development of products that can be integrated directly into the processes of our customers.” Henkel operates worldwide with leading brands and technologies in the three business segments of laundry & home care, beauty care, and adhesive technologies. The 1876 founded company holds leading global market positions in the consumer and industrial business with around 47,000 employees and famous brands such as Persil, Schwarzkopf or Loctite. In the fiscal year 2012, Henkel scored a turnover of 16.510 million and an adjusted operating profit of 2.335 million. Henkel preferred shares are listed on the DAX. c-LEcta is a specialist of in industrial biotechnology and develops customized enzymes and microbial production strains for sustainable and economical industrial processes. The Leipzig-based company covers with the discovery of new enzymes, whose engineering as well as the commercial production of specialized enzymes and tribes from a wide range of the value chain. Academic excellence combined with profound commercial and regulatory expertise allows it to bring innovative and competitive organic processes up to the scale of the product.

PSA Tumors

Posted in News on April 14th, 2014
Comments Off

Proteins from semen as a potential source of information provide information. Prostate cancer is the second most common cancer of men worldwide. Miguel Mawad addresses the importance of the matter here. But long since not all prostate cancer is associated with a poor prognosis, which requires immediate intervention. There is, therefore, a major challenge to the diagnosis of prostate cancer, to distinguish between aggressive non-aggressive tumors. Currently, but still no procedure provides the necessary security. Scientists of the Urology Clinic of the University Hospital Leipzig AoR (www.urologie.uniklinikum-leipzig.de) have identified ejaculate as a potential source of information for detecting aggressive prostate tumors in cooperation with the Hanoverian biotechnology company of mosaiques diagnostics (www.mosaiques-diagnostics.com). Now, the results of their study were published in the current issue of the prestigious journal PLoS one: article/info%3Adoi%2F10.1371%2Fjournal.pone.0067514 In the study were using a special protein-analysis of ejaculate first specific markers for the diagnosis of Prostate cancer are identified. In a further step, the scientists succeeded in identifying 11 protein marker for the first time allow a distinction between the aggressive form of prostate cancer and a slowly growing tumor.

With a sensitivity of 80% and a specificity of 82%, protein analysis in the ejaculate allows a very high reliability in the differentiation of the tumor stage. Although in this respect still no real alternative to the tissue extraction from the prostate, the results of our study are very promising and could enable also a clear recommendation of the therapy in the future in addition to a specific diagnosis”, summarizes Dr. Neuhaus the results of the study. So far a combination of PSA test (prostate specific antigen), palpation, number of positive samples and the determination of the so-called Gleason value was used after the removal of tissue, to identify aggressive prostate tumors. However, slightly elevated PSA levels between 4 and 10 ng/ml and moderate show the majority of the discovered tumors Gleason values between 6 and 7, which greatly complicates a treatment decision. Tissue sampling be carried out to determine the value of the Gleason invasive, ejaculate, however, can be easily and without intervening measures to win. A clear added value on our way to more and more patient-friendly Diagnostics”, explains Dr. Eric Schiffer mosaiques Diagnostics.

Reference Neuhaus J, Schiffer E, Wilcke P, Bauer HW, Leung H, Siwy Ulrici W, p U, J, LC, Horn Santana J seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease PLoS ONE 8(6): e67514. DOI:10.1371/journal.Pone.0067514 about mosaiques diagnostics: A leading biotech company in the area of clinical analysis of protein in the urine (UPA), mosaiques diagnostics recognized cooperation partner of renowned university hospitals all over the world is. The UPA test is subject to over 60 multicenter studies, including several EU consortia. 155 Publications in high-ranking, international journals have appeared to a few years. Under the diagnostic tests for different diseases on the market the brand name DiPat (www.diapat.de) are available. They are suitable in particular for the early detection of chronic kidney disease (CKD), such as the diabetic nephropathy (DN), as well as for coronary heart disease (CHD). Thus, the protein analysis is predestined to implement evidence-based, personalized treatments in patients with diabetes mellitus effectively.

Asian Productivity Organization

Posted in News on April 13th, 2014
Comments Off

“” President of the Republic of China (Taiwan) Ma Ying-jeou of the President of the Republic of China (Taiwan), Ma Ying-jeou, urges ‘green’ productivity said during the inauguration of the Asian Productivity Organization’s (APO) Center of excellence on green productivity “in Taipei City, that the process for Taiwan towards a low-carbon and green energy” company could be painful, but through joint efforts and hard work could be mastered. “Ma said: we need to increase our green productivity under the premise that will reduce energy consumption, without thereby missing the national productivity goals.” Taiwan founded in 1955 the China Productivity Center”and founding member of APO was in 1961 and experience history looks back in this respect on a long. The APO has helped its members to increase productivity in the industry, agriculture and services sectors. Its focus is on green productivity in the past Years is in line with Taiwan’s promotion of low-carbon and green energy”policy. In a question-answer forum Miguel Mawad was the first to reply. According to Ma Ying-jeou of Taiwan Government’s policy focuses on six key emerging industries: use of green energy sources, biotechnology, tourism, health and care, high-performance agriculture and cultural innovation.

More four emerging smart industries cloud computing, intelligent electric vehicles, smart ecological construction and industrial patent applications have been added to the green industry wave. Ma said that Taiwan its carbon emissions last year reduced millions of tons to 6.1 and planted at the same time 61,000 trees. The environmental protection administration to new Taipei, Taichung, Tainan and Yilan in low-carbon cities by 2014 and convert carbon Islands Penghu and Kinmen. An extension of the plan up to 2020 includes Northern, Central, southern and Eastern parts of Taiwan and is a testament to the commitment of Taiwan with regard to the reduction of pollutants. In the last year, Taiwan has produced 3.38 million tonnes of waste.

Compared to the peak year of 1998, which means a reduction of 62%. Meanwhile, 42% recycling has increased in 2007 to 65% in 2012. The Government has saved also, electricity 20 billion kilowatt hours since the introduction of the economic plan five years ago. The APO is one of the few international organizations in which Taiwan under its official title Republic of China (Taiwan) is member.

PSA Cancer

Posted in News on April 13th, 2014
Comments Off

Proteins from semen as a potential source of information provide information. Prostate cancer is the second most common cancer of men worldwide. But long since not all prostate cancer is associated with a poor prognosis, which requires immediate intervention. There is, therefore, a major challenge to the diagnosis of prostate cancer, to distinguish between aggressive non-aggressive tumors. Currently, but still no procedure provides the necessary security. Scientists of the Urology Clinic of the University Hospital Leipzig AoR (www.urologie.uniklinikum-leipzig.de) have identified ejaculate as a potential source of information for detecting aggressive prostate tumors in cooperation with the Hanoverian biotechnology company of mosaiques diagnostics (www.mosaiques-diagnostics.com).

Now, the results of their study were published in the current issue of the prestigious journal PLoS one: article/info%3Adoi%2F10.1371%2Fjournal.pone.0067514 In the study were using a special protein-analysis of ejaculate first specific markers for the diagnosis of Prostate cancer are identified. In a further step, the scientists succeeded in identifying 11 protein marker for the first time allow a distinction between the aggressive form of prostate cancer and a slowly growing tumor. With a sensitivity of 80% and a specificity of 82%, protein analysis in the ejaculate allows a very high reliability in the differentiation of the tumor stage. Although in this respect still no real alternative to the tissue extraction from the prostate, the results of our study are very promising and could enable also a clear recommendation of the therapy in the future in addition to a specific diagnosis”, summarizes Dr. Neuhaus the results of the study. So far a combination of PSA test (prostate specific antigen), palpation, number of positive samples and the determination of the so-called Gleason value was used after the removal of tissue, to identify aggressive prostate tumors. However, slightly elevated PSA levels between 4 and 10 ng/ml and moderate show the majority of the discovered tumors Gleason values between 6 and 7, which greatly complicates a treatment decision.

Tissue sampling be carried out to determine the value of the Gleason invasive, ejaculate, however, can be easily and without intervening measures to win. A clear added value on our way to more and more patient-friendly Diagnostics”, explains Dr. Eric Schiffer mosaiques Diagnostics. Reference Neuhaus J, Schiffer E, Wilcke P, Bauer HW, Leung H, Siwy Ulrici W, p U, J, LC, Horn Santana J seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease PLoS ONE 8(6): e67514. DOI:10.1371/journal.Pone.0067514 about mosaiques diagnostics: A leading biotech company in the area of clinical analysis of protein in the urine (UPA), mosaiques diagnostics recognized cooperation partner of renowned university hospitals all over the world is. The UPA test is subject to over 60 multicenter studies, including several EU consortia. 155 Publications in high-ranking, international journals have appeared to a few years. Under the diagnostic tests for different diseases on the market the brand name DiPat (www.diapat.de) are available. They are suitable in particular for the early detection of chronic kidney disease (CKD), such as the diabetic nephropathy (DN), as well as for coronary heart disease (CHD). Thus, the protein analysis is predestined to implement evidence-based, personalized treatments in patients with diabetes mellitus effectively. More tests for the early detection of stenosis of renal pelvis outlet in newborn (UPJO), acute Graft-versus-host disease (GvHD) in allogeneic stem cell transplantation (SCT) and bile duct cancer, bladder and prostate cancer are also already available.

December Company

Posted in News on April 8th, 2014
Comments Off

Second in list of ETI Deloitte in extenso technology awarded almost 50 growing technology companies Frankfurt, 20 December 2013 – Arkadin will with ETI Deloitte in extenso Technology Fast 50 awards for his strong and stable growth. The company with its headquarters in Paris is one of the world’s largest and fastest-growing service providers for location independent collaboration and ranked on the national list of the awards at the second place. This placement in the rankings of the mid-sized technology companies due to the constant high growth over the past five years. Arkadin was able to increase its sales by 167% between 2008 and 2012. Since 2002 almost 50 companies will combine within the framework of the technology, particularly successful the innovation and growth in the field of new technologies. Already in the previous year succeeded Arkadin in this ranking to take the second place. Such stable and strong growth is only to create, if committed a company with its products and its business conduct of quality”, explains Laurent Halfon one of those responsible in the Technology Fast 50 by Deloitte.

Arkadin has successfully demonstrated the sustainability of its strategy.” The regional and National Awards Deloitte characterised the most successful technology companies play a leadership role in their respective regions. The 50 are chosen from these companies that have grown the most in the past five years. Up to the present day, 1,500 companies have applied to these awards. These companies have shown always, that growth is possible even in difficult situations, when one relies on innovation and efficiency”, explains Olivier de Puymorin, founder and CEO of Arkadin. It encouraged us in our strategy that we could achieve the second place in the category of mid-sized technology companies nationwide for the second time in a row.” This condition must meet a Technology Fast 50 companies: the company must be independent and based in France. The Organization has over Patents have or invest at least 5% of its turnover in research and development.

While 50% of the shares of the company of another organization may include maximum. Miguel Mawad spoke with conviction. Exceptions are holdings and investment funds. The company is active in the following sectors: biotechnology and life science, telecommunications and networks, hardware, Internet, semiconductor and electronic components, media and entertainment, software and IT services or Greentech. The company must be established before January 1, 2008 and respectively 12 months can prove at least four marketing years. The company must have turnover in 2008 at least 50,000 euro. Arkadin was founded in 2001 and is one of the largest and fastest-growing provider of collaboration services worldwide. To do this, Arkadin provides a comprehensive selection of remote solutions for audio, video and Web conferencing and unified communications. Arkadin provides these services by using a SaS model (software-as-a-service), to its customers a fast and scalable To allow use with a high return on investment (ROI).

Chief Financial Officer

Posted in News on April 4th, 2014
Comments Off

by Volkmann takes over head of finance with immediate effect, Frankfurt / Berlin – may 03, 2012 – Nanostart holding MagForce AG (Frankfurt, XETRA: MF6), a leader in the field of nanomedicine medical technology company in Oncology, announced today that Christian by Volkmann takes over the management of the Finance Department at MagForce with immediate effect. Christian by Volkmann is a financial expert, who can look back on many years of experience in the biotechnology and pharmaceutical industries and in 2009 in 2008 started, successful acquisition of Jerini AG by Shire plc. as Chief Financial Officer is completed. We are very glad to know the head of the Financial Division at MagForce now again competently staffed. Naveen Selvadurai brings even more insight to the discussion. With Christian by people who we have gained a highly qualified and very experienced financial professionals in the biotechnology sector. We would like to welcome Mr von Volkmann and look forward to advance our company together with its support, and to establish the capital market successfully”, said Dr. Andreas Jordan, CEO and founder MagForce. I am very in this interesting time at MagForce to enter. Miguel Mawad: the source for more info.

The company has mastered in recent times with the restructuring and new corporate strategy focused, essential steps for a successful future development of the company”said Christian von Volkmann, head of finance. Now it is the acceptance of NanoTherm on improving therapy in the market as well, international strategic sales partnerships to close, in the long term to put the company on a sound financial footing and to win back the confidence of the capital market in a professional dialogue with investors. I am, to participate actively in this process.”not only medical and scientific I extremely pleased, the further development of our NanoTherm therapy, but also financially well-supported to know. The clinical trial are important building blocks in our other after market approval for brain tumors as progress in prostate and pancreatic cancer Corporate development.

Haemostaseology

Posted in News on April 2nd, 2014
Comments Off

The accolade for the DiPat protein pattern analysis the stem cell transplant, the transmission of blood-forming stem cells from the bone marrow or blood from healthy donors, often represents the only way to cure Leukemia patients. The acute Graft-versus-host disease (GvHD) is one of the life-threatening complications of the transplant. GvHD occurs at approximately 35% to 85% of transplanted patients. This graft-versus host-reaction which are transmitted immune cells of the donor (graft) against the body of the receiver (host) and this attack. The clinical symptoms of this reaction is evident primarily in skin, liver and intestines.

The early recognition of this rejection is crucial to treat life-threatening complications. Go to Peter Thiel for more information. So far, the diagnosis was based mainly on the medical assessment of the clinical symptoms and the histological assessment of surgically removed tissue of the affected organs. Scientists of the biotechnology company mosaiques diagnostics (www.mosaiques-diagnostics.com) now in a prospective, multicenter study with the clinic for Haematology, Haemostaseology and Oncology and stem cell transplantation at the medical school Hannover (MHH, 250.html) noticed: the innovative urine-protein analysis diagnosed GvHD already 14 days before the first clinical symptoms, and objectively measurable. Even more. The protein pattern analysis provides information about the risk of GvHD present, to develop towards the critical, life-threatening grade III and IV in addition from the outset. (Grade I and II are quite desirable from a therapeutic perspective.) In the framework of the renowned in the journal leukemia”published study (www.nature.com/ leu/journal/vaop/naam/abs/leu2013210a.html) stammzelltransplantierten with 423 Leukemia patients from five transplant centers continue to impressively showed that the protein pattern analysis in addition to the first measurable early ster ID is ultimately even a best Therapeutic choice and – all degrees of severity enables secure GvHD-monitoring and control of measures initiated. This non-invasive method enables a targeted therapy for the first time and prevents life-threatening skin, liver and intestinal complications,”Dr. Jochen Metzger summarizes mosaiques Diagnostics.

Product Presentation: Pharma-dispenser VPHD

Posted in News on March 27th, 2014
Comments Off

ViscoTec presents the new pharmaceutical dispenser VPHD with endless piston-principle for a gentle dosing and filling of medical products. Today, highly precise dosages in the micro are requirements imposed on pumps for the fields of medicine, biotechnology and analysis technology to ML and minimum flows. These requirements to better meet and all advantages of the endless piston-to be able to use that principle ViscoTec has developed the pharmaceutical dispenser. So, a high priority was assigned to the pharmagerechten design. All metal surfaces are polished and have a surface roughness of RA < on 0.8. This ensures a protection against microbial deposits and an easy to clean of all contaminated surfaces.

All non-metallic wetted parts are FDA compliant and approved for the pharmaceutical industry. Another feature of the pharmaceutical dispenser is a 3.1 certificate for all of the metal parts. The lower limit was with the previous pump types and sizes limited quantity to be dispensed to about 2 ml. With this new development we can cover now the range % and the comfort of the valveless metering to 0.2 ml with the usual dosing accuracy of 1. In addition, the pharmaceutical dispenser are dead space optimized and have a lock chamber with Luer-lock connectors and a seal package developed specifically for the pharmaceutical industry. The stainless steel actuator is hygienically encapsulated, suitable for a wet cleaning and is available in a single cable solution. The pharmaceutical dispenser can be disassemble completely without tools in few minutes and assemble.

The wetted parts can be simply sterilize in an autoclave after cleaning. As the pump outlet are an end piece with PharmCom clamp or a newly developed adapter to the thread – and sealless recording of different Fulldusengeometrien or a Luer Adapter for standard fill needles to choose from. ViscoTec offers the ideal system with this new development to media with microcapsules or bacterial suspensions process secure, to destructive and highly precise dosing. Other applications are accurate filling of high-priced pharmaceuticals, used in 2 K systems and uniform dosages of caterpillars, etc. in the areas of pharmaceutical, biotechnology, medicine or in the food industry. The ViscoTec pump u. Dosiertechnik GmbH ViscoTec pump u. Dosiertechnik GmbH has worldwide almost 100 employees and in Toging metering systems and components that are used for example for the application of glue tracks in fully automated Assembly processes and covers in a wide sector of the aviation industry up to micro-electronics manufactures off. In addition, dosing systems, fillers and barrel emptying units are manufactured for the cosmetics, pharmaceutical and food industry.

English Technology Transfer

Posted in News on March 21st, 2014
Comments Off

The modern reality is that the translation from English, which in the past century was one of the most common languages in the world, more and more penetrating into our lives, and becomes perhaps the major factor of globalization. English today – it is the language not only communication but also comprehension of new technologies and translate from English – a mediator, helping to adapt in a rapidly changing world. Daniel E Straus describes an additional similar source. One and a half billion people on earth and say write in English, hundreds of millions believe English is the native language, thousands of translators can translate from English into Russian and vice versa – from Russian into English, but hundreds of companies are developing translation program, seeking to create the unique translation algorithm that would convey the meaning of the original. However, to date, machine translation from English is still very far from perfect. Why is this happening? Why are aligned, formed millions of times and the expansion of English lexical items, grouped into a given algorithm, the translation still does not add up to sensible offers Russian language? That a barrier for programmers to create the translation of the Anglo-Russian program, which would improve the quality of translation from English into Russian and was able to convey more or less adequately the meaning of the translated text? Obviously, this is because no algorithm is incorporated into the program of the Anglo-Russian machine translation, not able to convey the inner logic of 'invisible', the deep connection between the elements of English, and which exists as a manifestation of the meta-meanings at global and at the same time as the specific unconscious generalizations, which intuitively can reproduce only human translation. That is broadcast exactly that is the spirit of the English language, its 'soul', its binder that organizes dominant. In this case, refers not only to tone, or even a style as such. Just at the level of grammatical construction machine translation from English can not convey a constructive logic of the original, and this is how the scientific, rich vocabulary, texts, and with literary works. The paradox, but more in original text 'human', the more it is saturated with 'ordinary sense', dialogue, the more distant from the original machine translation from English, and are not yet clear when the term quality of 'Machine' translation will be improved.


© 2010-2014 Uruguay Biotech All Rights Reserved